Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Pharmacology|December 26, 2024
Ophthalmic corticosteroids-related adverse events: the FDA adverse event reporting system (FAERS) database pharmacovigilance studyChengzhi Liu, Xinyu Wang, Xusheng CaoOcular Immunology and Inflammation|December 6, 2024
Research Trends of Ocular Tuberculosis: A Bibliometric AnalysisChengzhi Liu, Xinyu Wang, Xusheng CaoCellular Immunology|October 24, 2024
IL-10: A Key Regulator and potential therapeutic target in uveitisChengzhi Liu, Xinyu Wang, Xusheng CaoExpert Opinion on Drug Safety|April 7, 2025
A real-world disproportionality analysis of cidofovir from the FDA Adverse Event Reporting System (FAERS) databaseChengzhi Liu, Xinyu Wang, Chuanlie Zhou, et al.Nutrition Bulletin|July 9, 2025
Molecular Insights Into Carotenoid-Based Interventions for Diabetic RetinopathyChengzhi Liu, Xinyu Wang, Mingyue Liu, et al.Frontiers in Medicine|December 9, 2024
Atypical presentation of acute retinal necrosis mimicking Vogt-Koyanagi-Harada disease leading to misdiagnosis: a case reportWei Zhu, Cuiyun Yu, Qianqian Guo, et al.Computer Methods in Biomechanics and Biomedical Engineering|March 18, 2026
Uncovering the therapeutic mechanism of Baicalein in diabetic retinopathy through ferroptosis regulationChengzhi Liu, Yuanchao Fu, Shengnan Xu, et al.Life Sciences|March 9, 2025
Regulation of autophagy: Insights into O-GlcNAc modification mechanismsChengzhi Liu, Xinyu Wang, Shengnan Xu, et al.American Journal of Translational Research|April 8, 2017
Micro RNA-19a suppresses interleukin-10 in peripheral B cells of patients with diabetic retinopathyCong Wang, Qisheng You, Xusheng Cao, et al.Quantitative Biology (Beijing, China)|February 12, 2026
DeepDrug: A general graph-based deep learning framework for drug-drug interactions and drug-target interactions predictionQijin Yin, Rui Fan, Xusheng Cao, et al.Pageof 3